[ Ссылка ] - The combination of symptoms (shortness of breath, fatigue, chest pain, palpitations) and a diagnosis of "severe" mitral valve regurgitation are key indicators for timing mitral valve surgery.
But... What about patients who are asymptomatic and have a severely leaking mitral valve caused by mitral valve prolapse? Should these patients be operated on BEFORE the onset of symptoms?
To learn more, we just interviewed Dr. Patrick McCarthy, the Chief of Cardiac Surgery at Northwestern Medicine in Chicago, Illinois, about his new research paper, "Asymptomatic Degenerative Mitral Regurgitation: Validating Guidelines for Early Intervention".
During this video, you will learn key findings and recommendations from Dr. McCarthy's research of 1,000+ mitral valve patients including:
- Asymptomatic patients with severe mitral regurgitation that wait "too long" to undergo surgery are at risk for irreversible cardiac damage.
- Early surgery for asymptomatic mitral valve patients had 0% mortality at 30 days.
- In Dr. McCarthy's research paper, there was 0% mitral valve re-operations for asymptomatic patients 10 years after surgery.
- Only 2% of patients had mitral valve leakage at a level of 3 (out of 4) following mitral valve repair surgery.
The research presented by Dr. Patrick McCarthy and Northwestern Medicine supported the ACC/AHA Guidelines for the Management of Heart Valve Disease which recommends early treatment of severe mitral regurgitation for asymptomatic patients.
To see 150+ patients reviews and a complete surgeon biography for Dr. McCarthy, please visit [ Ссылка ].
